SPDR S&P Biotech ETF (NYSEARCA:XBI) Holdings Raised by SG Americas Securities LLC

SG Americas Securities LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 78.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 106,106 shares of the exchange traded fund’s stock after purchasing an additional 46,718 shares during the quarter. SG Americas Securities LLC owned 0.14% of SPDR S&P Biotech ETF worth $9,556,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the stock. Albion Financial Group UT purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $158,000. Howard Capital Management Group LLC boosted its stake in SPDR S&P Biotech ETF by 2.4% in the 4th quarter. Howard Capital Management Group LLC now owns 254,166 shares of the exchange traded fund’s stock worth $22,890,000 after purchasing an additional 6,052 shares during the period. Atomi Financial Group Inc. grew its position in SPDR S&P Biotech ETF by 224.2% during the 4th quarter. Atomi Financial Group Inc. now owns 7,248 shares of the exchange traded fund’s stock worth $653,000 after purchasing an additional 5,012 shares in the last quarter. Gilman Hill Asset Management LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $203,000. Finally, Mission Hills Financial Advisory LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 14.3% in the fourth quarter. Mission Hills Financial Advisory LLC now owns 36,111 shares of the exchange traded fund’s stock valued at $3,252,000 after purchasing an additional 4,531 shares in the last quarter.

SPDR S&P Biotech ETF Stock Up 1.9 %

Shares of SPDR S&P Biotech ETF stock opened at $92.98 on Friday. The stock has a market cap of $7.09 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The business has a fifty day simple moving average of $93.33 and a 200-day simple moving average of $96.88.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.